However, after adjusting tumor size, lymph node metastasis, and TNM staging, multiple Cox regression revealed that RUFY3 expression could be considered an independent factor for predicting survival in lung adenocarcinoma patients. The gene discussed is RUFY3; the disease is metastatic malignant neoplasm in the lymph nodes.